Xoma Corporation

Developer of antibody-based therapeutics for treating endocrine/metabolic diseases

placeBerkeley, California, United States calendar_todayFounded 1981 groups12 employees language xoma.com

Registered entities

Social engagement

Social engagement: 6.2K social following, 9 posts in the last 12 months — below the industry typical range.

Investor mix

7 investors on record.

Investor typeCountShare
Venture capital343%
Private equity114%
Bank & private debt114%
Other / undisclosed229%

Recent activity

18 Mar 2026
Milestone
revenue
22 Jan 2026
Leadership hire
Chief Financial Officer
13 Aug 2025
Milestone
regulatory
Coming soon